BridgeBio Pharma
BBIO
#1405
Rank
NZ$27.07 B
Marketcap
NZ$138.98
Share price
-2.75%
Change (1 day)
14.58%
Change (1 year)

Earnings for BridgeBio Pharma (BBIO)

Earnings in 2026 (TTM): -NZ$0.64 Billion

According to BridgeBio Pharma 's latest financial reports the company's current earnings are NZ$0.94 Billion. In 2025 the company made an earning of -NZ$1.02 Billion a decrease over its 2024 earnings that were of -NZ$0.81 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BridgeBio Pharma from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.64 Billion-37.62%
2025 -NZ$1.02 Billion25.14%
2024 -NZ$0.81 Billion-22.56%
2023 -NZ$1.05 Billion41.5%
2022 -NZ$0.74 Billion-25.1%
2021 -NZ$0.99 Billion15.11%
2020 -NZ$0.86 Billion67.55%
2019 -NZ$0.52 Billion67.65%
2018 -NZ$0.31 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-NZ$0.3 Billion-56.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-NZ$33.19 Million-95.00%๐Ÿ‡บ๐Ÿ‡ธ USA